Federal government repaying Indiana hospitals $222M for improper reimbursement cuts
After a bruising, five-year fight that went all the way to the U.S. Supreme Court, hospitals across Indiana and the nation are in line for a huge payday.
Pharmaceutical
Articles
Ozempic causing ‘slight pullback’ by shoppers, Walmart says
Walmart Inc. says it’s already seeing an impact on shopping demand from people taking the diabetes drug Ozempic, Wegovy and other appetite-suppressing medications.
Lilly buys radiopharmaceutical startup Point Biopharma for $1.4B
Eli Lilly and Co. is paying Indianapolis-based startup Point Biopharma $12.50 a share, an 85% premium over the company’s closing price on Monday of $6.68 a share.
FDA rejects Lilly drug for eczema due to inspection issues at outside manufacturer
Eli Lilly and Co. just hit another bump in the road in its quest to push deeper into treatments for skin diseases, the third setback this year for the Indianapolis-based drugmaker from the U.S Food and Drug Administration.
Judge overturns $176.5M jury verdict against Lilly in patent infringement suit
The decision represents a rare case of a judge overturning a jury verdict and is a major win for Lilly, which argued strenuously that its Emgality drug is substantially different than Anjovy, a drug sold by competitor Teva Pharmaceuticals.
Lilly to install $10M worth of solar panels at two Indianapolis campuses
The solar structures are designed to help generate power for the company and reduce its carbon footprint.
AI tools are helping researchers discover new drugs more quickly
During the last nine years, the cumulative amount of AI investments across the pharma and biotech sectors has increased by almost thirtyfold, to $24.6 billion as of last December.
Eli Lilly sues businesses selling knockoff versions of Mounjaro
Lilly is suing medical spas, wellness centers and compounding pharmacies in various U.S. states that sell unapproved versions of its blockbuster diabetes drug, which is frequently used off-label for weight loss.
Biotech firm nearing completion of Indy radioisotopes factory
Following a $45 million renovation, RayzeBio plans to use the plant to make Actinium 225, a radioisotope used for targeted therapy for cancer.
Israeli pharmaceutical company to build $20M facility in Westfield
Isotopia USA, the newly formed U.S. subsidiary of Isotopia Molecular Imaging, announced Monday that it will hire 50 people to produce a radioactive medical isotope used in pharmaceuticals for targeted cancer treatment.
Popular nasal decongestant doesn’t actually relieve congestion, FDA advisers say
The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts.
FDA approves new COVID vaccine as respiratory illness season nears
If the Centers for Disease Control and Prevention signs off Tuesday, injections could be available in pharmacies, clinics and doctor’s offices by the end of the week.
Eli Lilly’s Jardiance among 10 prescription drugs chosen for price negotiations
The Biden administration is targeting diabetes treatment Jardiance and nine other medications for Medicare’s first-ever drug price negotiations as it seeks to lower medical costs for Americans.
Makers of billion-dollar drugs set to face their first U.S. price negotiations
Analysts expect Johnson & Johnson’s Xarelto blood thinner and Indianapolis-based Eli Lilly and Co.’s Jardiance for diabetes to be among the medications chosen.
Lilly stock skyrockets, raising profile of city’s life sciences sector
The pharmaceutical company has launched 20 drugs in the past decade to treat diseases from arthritis and psoriasis to diabetes and cancer. In recent months, Lilly has overtaken every competitor to become the most valuable drugmaker in the world.
U.S eyes battle with drug giants over 10 costly medications for seniors
The list is expected to arrive within the next two weeks, and industry experts believe it will include some of the most widely prescribed treatments for arthritis, blood disorders, heart disease and diabetes.
Popular weight-loss drugs might raise risk of complications under anesthesia
Some anesthesiologists in the U.S. and Canada say they’ve seen growing numbers of patients on the weight-loss drugs who inhaled food and liquid into their lungs while sedated.
Supreme Court pauses Purdue Pharma $6 billion settlement plan
Thursday’s decision means settlement money meant for thousands of victims and their relatives and for local and state governments could be delayed.
Lilly stock soars to all-time high on strong sales, led by Mounjaro
Much of the excitement is due to strong results from Mounjaro, which hit the market in June 2022 as a treatment for Type 2 diabetes and rang up $979.7 million in the quarter.
Lilly reports surging profit, raises full-year guidance
The Indianapolis-based pharmaceutical company’s first-quarter performance was driven by strong sales of leading drugs for diabetes, cancer and other diseases.